A severe case of hidradenitis suppurativa with chronic anemia treated with adalimumab

J Dermatol. 2023 Jan;50(1):e22-e23. doi: 10.1111/1346-8138.16571. Epub 2022 Sep 8.

Authors

Hiroki Arakawa¹, Takeya Adachi^{1

2

3}, Yuki Kobayashi¹, Toyoko Inazumi¹

Affiliations

¹ Department of Dermatology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
² Department of Medical Regulatory Science, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
³ Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

PMID: 36074661
DOI: 10.1111/1346-8138.16571

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adalimumab / therapeutic use
Anemia* / drug therapy
Anemia* / etiology
Anti-Inflammatory Agents / therapeutic use
Hidradenitis Suppurativa* / complications
Hidradenitis Suppurativa* / diagnosis
Hidradenitis Suppurativa* / drug therapy
Humans
Treatment Outcome

Substances

Adalimumab
Anti-Inflammatory Agents

Grants and funding